Alisporivir With pegIFN/RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C

Inclusion criteria:

1. HCV GT1 patients with previous PI treatment failure.

2. Timing of the PI treatment. the minimum time from the last dose of previous PI
treatment to the first dose of study medication is three months.

3. Diagnosed Chronic hepatitis C virus infection

4. Infection with HCV genotype 1

Exclusion criteria:

1. Use of other investigational drugs at the time of enrollment,

2. History of hypersensitivity to any pegIFN or RBV.

3. Any null non-responders to prior pegIFN/RBV treatment,

Other protocol-defined inclusion/exclusion criteria may apply.